![Li Deng-Ke](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Li Deng-Ke served as President, CEO, CFO, Director & CAO at Rich Pharmaceuticals, Inc. from 2012 to 2013.
Prior to that, he worked as a Technician at KTV Ltd.
Mr. Deng-Ke received his undergraduate degree from Sichuan Normal University in 2006.
Antiguos cargos conocidos de Li Deng-Ke.
Empresas | Cargo | Fin |
---|---|---|
RICH PHARMACEUTICALS, INC. | Director Financiero/CFO | 29/03/2013 |
KTV Ltd. | Corporate Officer/Principal | - |
Formación de Li Deng-Ke.
Sichuan Normal University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Rich Pharmaceuticals, Inc.
![]() Rich Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rich Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages on developing innovative therapies in oncology. It develops RP-323 for the treatment of Hodgkin’s lymphoma, Acute Myelogenous Leukemia, and to cause elevation of white blood cells in patients depleted of these elements due to various conditions. The company was founded on August 9, 2010 and is headquartered in Beverly Hills, CA. | Health Technology |
KTV Ltd. |
- Bolsa de valores
- Insiders
- Li Deng-Ke